SpineX reports successful first in human study results of SCONE therapy
SCONE, a non-invasive transcutaneous spinal cord neuromodulator is the first of its kind device that is being developed to treat bladder dysfunction.SpineX, Inc., an early-stage medtech company has announced the publication of new data in the esteemed journal, BioElectric Medicine demonstrating the positive effects of SCONE therapy to treat Urge Urinary Incontinence.To read the full...
Login or Register to read the full article
SCONE, a non-invasive transcutaneous spinal cord neuromodulator is the first of its kind device that is being developed to treat bladder dysfunction.
SpineX, Inc., an early-stage medtech company has announced the publication of new data in the esteemed journal, BioElectric Medicine demonstrating the positive effects of SCONE therapy to treat Urge Urinary Incontinence.
To read the full story, click on the following link:
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd